International Journal of Molecular Sciences, Volume 26, Issue 16
2025 August-2 - 451 articles
Cover Story: Glioblastoma (GBM) is a highly aggressive brain tumour characterised by a poor prognosis and resistance to anti-angiogenic treatments. Vasculogenic mimicry (VM), in which tumour cells form vessel-like structures independent of endothelial cells, is an emerging mechanism hindering the efficacy of anti-angiogenic therapies. Recent research highlights the central role of RNA-binding proteins (RBPs) in regulating VM through diverse post-transcriptional mechanisms. However, RBP-targeting compounds aimed at suppressing VM in GBM remain scarce. This review summarises the role of VM in the treatment resistance of GBM and the RBP regulation of VM and proposes directions for future research on RBP-targeted therapies aimed at overcoming VM-mediated treatment resistance in GBM. View this paper - Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.